DermBiont is at the intersection of two highly active sectors: dermatology and the microbiome. We harness naturally occurring microbes on the human skin that have evolved over hundreds of thousands of years to compete with pathogenic microbes (fungi, bacteria, viruses, etc.).

While most of the microbiome work to date has concentrated on the human digestive system, we believe that the optimal starting point is to employ "bugs as drugs" for the therapeutic treatment and ongoing prevention of various skin conditions.